BusinessMadrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical AchievementsBy Nasdaq OMXMay 8, 2018, 10:50 AM UTC
BusinessChemioCare Announces Addition of Chief Medical Advisor and DirectorBy Nasdaq OMXMay 1, 2018, 2:00 PM UTC
BusinessIndia Globalization Capital: The Best of Both Worlds Approach -- CFN MediaBy Nasdaq OMXMay 1, 2018, 1:48 PM UTC
BusinessTikaMobile Launches TikaMSL, an Innovative Analytics CRM Platform for Medical Science Liaisons Designed to Drive Key Opinion Leader DevelopmentBy Nasdaq OMXApr 30, 2018, 12:01 PM UTC
BusinessAxiom Real-Time Metrics Exhibiting Fusion eClinical Suite at Clinical Operations in Oncology Trials WestBy Nasdaq OMXApr 23, 2018, 11:12 PM UTC
BusinessAXIM Biotech Secures Additional Funding to Advance Cannabidnoid-Based Clinical Development Program for Multiple IndicationsBy Nasdaq OMXApr 23, 2018, 1:00 PM UTC
BusinessAXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal ActivitiesBy Nasdaq OMXApr 18, 2018, 1:01 PM UTC
BusinessRich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML PatientsBy Nasdaq OMXApr 10, 2018, 11:01 AM UTC
